Found 11 matching trials
Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People With Multiple Sclerosis PHASE1 Background:
\- Contrast agents are drugs that make certain body areas or a...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Manganese-Enhanced Magnetic Resonance Imaging of the Myocardium N/A Scanning the heart using magnetic resonance imaging (MRI) enables detailed ...
Show More Location
Queen's Medical Research Institute, University of Edinburgh
Learn More & Join Trial
Mangafodipir as an Adjunct to Percutaneous Coronary Intervention PHASE2 The present feasibility study is designed to find out whether pre-treatment...
Show More Location
Department of Internal Medicine, County Hospital Ryhov
Learn More & Join Trial
MEMRI and Kidney Disease N/A Acute kidney injury (AKI) is common and costly.1 Although patients who suff...
Show More Learn More & Join Trial
Mangafodipir - an Intracellular Contrast Agent for Magnetic Resonance Imaging (MRI): Measuring Manganese Uptake Rate in Heart Failure Patients With Preserved Ejection Fraction (HFpEF) Patients. PHASE2 More than half of heart failure patients have preserved ejection fraction (...
Show More Location
Oslo University Hospital, Department of Cardiology, Rikshospitalet Sognsvannsveien 20
Learn More & Join Trial
Manganese-enhanced Magnetic Resonance Imaging (MEMRI) in Heart Failure With Preserved Ejection Fraction N/A Heart failure with preserved ejection fraction (HFpEF) is a condition in wh...
Show More Location
University of Leicester
Learn More & Join Trial
Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Colon Cancer Stage Dukes' C PHASE2 The present feasibility study is designed to find out whether pre-treatment...
Show More Location
Onkologkliniken, Länssjukhuset Ryhov
Learn More & Join Trial
Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy PHASE1 Background:
\- The blood-brain barrier separates the brain from the rest o...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus N/A Background: Heart failure is a major cause of morbidity and mortality in di...
Show More Location
University of Leicester
Learn More & Join Trial
Protective Effect of Mangafodipir Against Oxaliplatin Neurotoxicity PHASE2 Oxaliplatin is a major antitumor agent but its use is limited by potentiall...
Show More Learn More & Join Trial